Efficacy and safety of intradetrusor onabotulinumtoxinA injection for managing paediatric non-neurogenic overactive bladder: A prospective case-series study
2019
ABSTRACTObjectives: To evaluate the outcome of intradetrusor onabotulinumtoxinA (Botox®; Allergan Inc., Dublin, Ireland) (IDB) injection in children and adolescents with non-neurogenic overactive b...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
28
References
2
Citations
NaN
KQI